Bahir Dar Child Development Study, Ethiopia
BCD
1 other identifier
observational
471
1 country
1
Brief Summary
The goal of this observational study is to learn about typical neurodevelopment in children aged 6 months to 5 years who live in Bahir Dar, Ethiopia. The main aims of the study are: Aim 1: To characterize typical neurodevelopment as measured by i) brain volume using low-field MRI and ii) scores on behavioral assessments of early child neurodevelopment. Aim 2: To characterize typical pre-academic school skills in early childhood as measured by tasks of visual processing, reasoning, verbal expression and school readiness. Aim 3: To identify factors influencing child development in a community in Bahir Dar, Amhara region of Ethiopia, as measured by validated measures of maternal mental health, home environment, and childhood adversity. Participants will complete one low-field MRI scan at enrollment, have a hemoglobin blood test, and undergo age-appropriate neurodevelopmental assessments and surveys that may include:
- WHO Global Scales for Early Development (GSED) \[ages 6 - 36 months\]
- Tasks of visual reasoning and verbal expression \[ages 48-60 months\]
- Executive Functions test using the tablet-based NIH Toolbox \[ages 48-60 months\]
- School Readiness questionnaire assessing knowledge of literacy, numeracy, early reading, crystallized knowledge, memory, and self-regulation \[ages 48-60 months\]
- Maternal report of child's motor, cognitive and socioemotional skillsChild Anthropometrics assessment Additional assessments of the participant's family and environment will include
- Medical History questionnaire
- Family socioeconomic status
- Maternal Mental Health
- Recent Life Events and hardship
- Home Environment and Parenting UNICEF's MICs Family Care Indicators)
- Food security and feeding practices
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 29, 2024
CompletedFirst Submitted
Initial submission to the registry
October 8, 2024
CompletedFirst Posted
Study publicly available on registry
October 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 11, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedMarch 11, 2026
March 1, 2026
7 months
October 8, 2024
March 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total Brain MRI volumes
Total supratentorial brain volume measured from Hyperfine MRI uzing standard processing pipelines for infant MRI progressing. Outcomes will be reported in cm3.
Collected in all children (ages 6-60 months) at enrollment.
Secondary Outcomes (8)
WHO Global Scales for Early Development (GSED)
Collected in children aged 6-36 months at enrollment.
Visual reasoning
Collected in children aged 48-60 months at enrollment.
School readiness
Collected in children aged 48-60 months at enrollment.
Executive Functioning: cognitive flexibility and attention
Collected in children aged 48-60 months at enrollment.
Self-regulation
Collected in children aged 48-60 months at enrollment.
- +3 more secondary outcomes
Study Arms (8)
A/6 months
Measures of child development (GSED), nutrition, medical history and anthropometrics, followed by MRI
B/12 months
Measures of child development (GSED), nutrition, medical history and anthropometrics, followed by MRI
C/18 months
Measures of child development (GSED), nutrition, medical history and anthropometrics, followed by MRI
D/24 months
Measures of child development (GSED), nutrition, medical history and anthropometrics, followed by MRI
E/30 months
Measures of child development (GSED), nutrition, medical history and anthropometrics, followed by MRI
F/36 months
Measures of child development (GSED), nutrition, medical history and anthropometrics, followed by MRI
G/48 months
Measures of child neurocognitive development and school readiness, nutrition, medical history, and anthropometrics followed by MRI
H/60 months
Measures of child neurocognitive development and school readiness, nutrition, medical history, and anthropometrics followed by MRI
Eligibility Criteria
Children will be identified at rural health centers, outpatient vaccination clinics or campaigns, and other health facilities around Bahir Dar, Amhara, Ethiopia.
You may qualify if:
- Children living in Bahir Dar town with parents who are willing and able to travel to Felege Hiwot Regional Hospital clinic for study visits
- Healthy child without active clinical symptoms/complaints
- Child within specified age ranges for each cohort/group (+/- 2 months)
You may not qualify if:
- Child born with a severe congenital birth defect or hypoxic ischemic encephalopathy (birth asphyxia) per maternal report
- Severe developmental or behavioral disorder per maternal report
- Severe illness/clinical signs or symptoms of illness based on maternal and child report (including vomiting, headache, or seizures)
- Plans to move out of catchment area in less than 1 year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brigham and Women's Hospitallead
- Addis Continental Institute of Public Healthcollaborator
- New York Universitycollaborator
- Boston Children's Hospital, Boston, MA, USAcollaborator
Study Sites (1)
Health Center
Bahir Dar, Addis, Ethiopia
Related Publications (1)
Jensen SKG, Yibeltal K, North K, Workneh F, Teklehaimanot A, Abate BH, Fasil N, Melka TL, Chin TI, Folger LV, Roy Paladhi U, Van Dyk F, Thomason ME, Grant PE, Inder T, Worku A, Berhane Y, Lee AC. Bahir Dar Child Development Cross-Sectional Study, Ethiopia: study protocol. BMJ Paediatr Open. 2025 Apr 2;9(1):e003173. doi: 10.1136/bmjpo-2024-003173.
PMID: 40180427DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne C Lee, MD, MPH
Brigham and Women's Hospital
- PRINCIPAL INVESTIGATOR
Yemane Berhane, MD, PhD
Addis Continental Institute of Public Health
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director Global Newborn Health
Study Record Dates
First Submitted
October 8, 2024
First Posted
October 18, 2024
Study Start
April 29, 2024
Primary Completion
November 11, 2024
Study Completion
December 1, 2024
Last Updated
March 11, 2026
Record last verified: 2026-03